MS News From the AAN Meetings: Significant Risks From Tysabri Identified - Multiple Sclerosis Blog
Links shared publicly online about this topic.
- 351total visits
MS News From the AAN Meetings: Significant Risks From Tysabri Identified - Multiple Sclerosis Blog
Alfred Sandrock, MD, PhD, of Biogen/Idec, presented findings from the company--™s study on progressive multifocal leukoencephalopathy (PML) in patients using Biogen/Idec--™s MS drug, Tysabri --" a drug that has garnered the name --poison-- from some critics.
View full resource at everydayhealth.com
Tags: Neurology, Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Tysabri, Doctor, News
Most Recently Shared on April 20, 2011 at 6:54 pm By:
#MultipleSclerosis News: The American Academy of Neurology meeting IDs big from #Tysabri http://ow.ly/4Etp9 @trevisgleason
Advertisement
